Background: Hepatitis C virus (HCV) has been reported to be the most common cause of chronic viral Hepatitis with increased prevalence rate worldwide. HCV genotype is an important predictive factor in the outcome of HCV treatment, therefore an essential component of clinical practice. Molecular methods are the most common diagnostic tools for HCV genotyping. HCV genotype might also have relevance for newer antiviral therapies in development.
INTRODUCTION
Hepatitis is simply the inflammation of the Liver caused by factors such toxins, chemicals, drugs, heavy alcohol use and other genetic and metabolic disorders. These can damage the liver and hence are called non-infectious hepatitis because they cannot spread from one person to another. 1 Hepatitis infection can result in acute or chronic disease which leads to destruction of liver cells, a condition known as cirrhosis. 2 Hepatitis C virus (HCV) has been reported to be the most common cause of chronic viral Hepatitis with increased prevalence rate worldwide. 150 million people were reported to be infected with HCV by 1997 worldwide. 3 It is dubbed the "silent epidemic". 1 Dryer, Limketai et al. 5 report estimated that 170 million people are infected with HCV worldwide.
Hepatitis C virus is a positive-strand RNA virus that contains a genome of about 10,000 nucleotides with a single, large continuous open reading frame 5 flanked by 5' and 3' untranslated regions 6 and belongs to the blood-borne flaviviridae family, and the genus hepacivirus. 7 Hepatitis C is considered as a major global public health problem. "Throughout the world, blood transfusion from infectious donors, unsafe therapeutic injection practices, and illegal injection drug use have been the predominant modes of spread for HCV, with substantial geographic differences in their relative contributions to disease burden". 5 There are more than 60 known HCV genotypes and subtypes distributed worldwide. Six major genotypes (1,2,3,4,5 and 6) are reported to be of great significance. 8 Antiviral therapy for HCV consists of pegylated interferon and ribavirin. However, the therapeutic response rates differ from one HCV genotype to another. Therefore, accurate HCV genotyping is an important predictor for treatment. 9, 10 HCV genotyping is important in clinical practice as it offers new avenues for antiviral therapy development. The genotypes have varied geographical distribution. 10 In the United Kingdom, genotype 1 is the most common (40-50%) followed by genotypes 2 and 3 which account for another 40-50% of HCV cases and finally genotypes 4, 5 and 6.
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Figure 1 below; represent the HCV genome organisation, the structural and non-structural proteins expressed within the polyprotein precursor encoding region. During the time of this study, there was no virology laboratory that genotypes HCV onsite in Liverpool.
5'NTR
The Virology department at the Royal Liverpool University Hospital (RLUH) was referring samples for HCV genotype testing to an external reference laboratory. This had a negative effect on results 'turn-around time' and possibly the cost. It was the aim of this study to evaluate the three methods of HCV genotyping using analytical instruments that were in place at RLUH.
Conventional and Real-time Polymerase Chain Reaction (PCR) was used to detect and distinguish HCV genotypes on surplus known HCV positive blood samples referred to RLUH virology laboratory for HCV testing. The gold standard method for HCV genotyping was HCV genomic sequence data for the viral non-structural 5b (NS5b) gene.
MATERIALS AND METHODS

Patient Samples
A total of 71 plasma and serum samples were collected from surplus HCV positive samples stored at the Royal Liverpool University Hospital virology department which were kept in the freezer at -70 o C. Individual laboratory numbers were used to store samples in virology department. The samples were identified and the patient information was checked on Telepath information system. No patient names were used in the study except special study numbers.
The HCV genotype panel, Quality control for molecular diagnostics (QCMD) and the NIBSC panels were used in the assay evaluation. The external quality assurance (EQA) panel consisted of blind (QCMD) and known (NIBSC) genotypes.
Nucleic acid isolation
The plasma or serum samples were defrosted at room temperature, vortex for 5 seconds and centrifuged at 13000rpm for 30 seconds. Total nucleic acid was extracted from 800μl of plasma or serum by use of automated QIAGEN-QIAsymphony using the QIAsymphony ® Virus/Bacteria Midi Kit 96 following the manufacturer's instructions. RNA extraction was estimated on QIAsymphony using 'pathogen complex 800 V3' or 'virus Cellfree 1000 V3 default IC' protocols following the manufacturer's instructions. The elution volume was 85μl. A proportion of samples were also processed using QIAGEN-QIAcube using QIAamp® MiniElute® Virus kit following the manufacturer's instructions. A volume of 400μl of plasma or serum was used on QIAcube for the extraction of RNA under the large body fluid sample protocol. The elution volume was 60μl. All the purified nucleic acid preparations were stored in the freezer at -70 o C.
Primers and Probes
Primer sets targeting the 5'Nontranslated region (5'NTR) and NS5b regions of HCV were used for the real-time PCR and sequencing PCR respectively. The Primers and probes were purchased from Metabion GmbH and Eurofins (Germany) in 100μM concentrations. The lyophilized primers were firstly reconstituted with the given amount of molecular water to make 100mM stocks. The working primer solutions were generated by mixing the forward and reverse primers to form different working primer mixes e.g. NS5b(A), NS5b(B), NS5b(C) and NS5b(D).
The real-time RT-PCR was performed based on the hybridization probe assay designed by (Bullock, Bruns et al. 2002) 3 using two primers with complementary sequences that are located in the 5 ' -NTR of the HCV genome conserved among major HCV genotypes. The forward and reverse primers were modified in order to improve the assay performance. Different primer sets were tried in order to optimise the reactions. Table 1 below summarizes all the primer and probe sets which were modified for optimisation of the 5 ' NTR PCR assay. 
Real-Time PCR
The real-time RT-PCR was performed based on the hybridization probe assay designed by (Bullock, Bruns et al. 2002) 3 in a two-step real-time PCR reaction on LightCycler® FastStart DNA Master Hybridization probe kit (Roche) using two primers with complementary sequences that are located in the 5 ' -NTR of the HCV genome conserved among major HCV genotypes. The forward and reverse primers were modified in order to improve the assay performance. Different primer sets were tried in order to optimise the reactions. The hybridization probes were based on the resonance energy transfer (FRET) method and they contained oligonucleotides labelled with different fluorescent dyes.
In order to improve the laboratory protocol, the 5'-NTR assay was assessed as a one-step PCR protocol using different kits (i. For confirmation of amplification and size of PCR products, 1.5% of agarose gel was prepared for separation of DNA fragments. PCR products (5μl) were loaded with an equal volume of Invitrogen blue juice dye into the gel wells. The electrophoresis running conditions were set at 130V, 122mA and 16W for 25min. The Hyperladder II (molecular marker) was used to compare the gel bands.
RESULTS
Nucleic acid extraction
The RNA was properly extracted with QIAGENQIAsymphony and QIAcube automated equipment. The QCMD panel was initially extracted using QIAsymphony but two samples were negative. When the same samples were re-extracted on QIAcube, all the samples were positive. This showed that QIAcube extracts produced better PCR products than QIAsymphony (which could be less sensitive on low viral loads). Of the 8 QCMD panel samples, 7 projects results matched with the reference genotypes except 1 sample.
HCV 5 ' NTR and Sequencing PCRs SYBR ® Green Assay
The primer mixes were analysed using QuantiTect SYBR ® Green RT-PCR Kit. Since there were less differences in gel band sizes, one primer set (Primer NS5b(A) was chosen to be used for the rest of the project. We needed F2+R2 primer to specifically amplify genotype 1. When 5μl of RNA was used in the initial SYBR ® Green RT-PCR reaction, there were many primer-dimer formations. The primerdimers were less when the RNA was increased to 20μl in each SYBR ® Green RT-PCR reaction. Increasing the RNA in the reaction also increased the PCR sensitivity. However, changing the annealing temperatures did not improve anything.
Denaturing the RNA at 95 o C on block heater increased the PCR products yield.
Two-step hybridization probe (5 ' NTR PCR)
The two-step real-time PCR using RocheTranscriptor High Fidelity cDNA Synthesis and Roche-Lightcycler® FastStart DNA Master Hybridization probe kits gave good results but could not be continued since the main objective was to assess a one-step PCR method for diagnostic purposes. The reverse transcription and PCR done as separate procedures (two tubes) is tedious and subjected to contaminations.
One-Step Hybridization Probe
The In-house primer and probes could bind well especially on genotype 1 but there was amplification in some genotypes. There were many primer-dimer formations. The melting temperature for some few samples were low (49.36 o C and 57.12 o C) instead of being above 80 o C. For this reason the probes could probably not bind at such low temperatures, hence the inability to amplify some samples.
Hybridization probe modifications
Modifying the reaction volumes and changing the primer sets only genotype 1 could be amplified on In-house mastermix but the band sizes on the gel were not impressive.
LightCycler® RNA Master HybProbe kit
The Real-Time ready RNA virus reagents cycling parameters were not compatible with the manufacturer's instructions and the probes could not bind well. Doubling the primer volume did not improve anything. The new LightCycler® RNA Master HybProbe reagents did not work. Modifying the RT time and doubling the primer and probe volumes did not improve anything as well.
NS5B Sequencing
Comparison of 3 different Kits
The initial primer sets tested on SYBR Green indicated that primer NS5b(A) was better and was tried on the other two kits; Invitrogen and Qiagen. Primer NS5b(A) worked on all the three reagents however, Qiagen produced better gel bands than SYBR Green and Invitrogen. All the subsequent runs were done using Qiagen® one-step RT-PCR kit. Doubling the purified RNA volume to 20μl in each Qiagen reaction volume increased the sensitivity and reduced the primer-dimer formations.
HCV sequence PCR
In initial PCR products purification where 10μl was eluted, the quality of sequence was good. When the elution volume was increased to 50μl, there were mixed sequence qualities possibly due to dilution errors. Out of 71 samples only 65 gave definitive results. 6 were not amplified. Table 3 summaries all the project HCV results. 
Project genotype HCV Genotype
Statistical analysis
Out of the 71 samples, 65 were analysed using SPSS in order to measure the agreement between the two methods (i.e. The project and Reference HCV genotyping) using Kappa statistical test. The remaining 6 samples were not amplified, hence their exclusion from Kappa analysis. showed agreement with minor discordants in subtypes and 6 were mismatches. We also participated in the external quality assurance programme with unknown and known HCV genotype samples from QCMD and NIBSC respectively. Of the 8 plasma samples (QCMD panel), results for 7 samples were concordant with the expected reference results and 1 was discordant. Therefore, of the 6 known HCV genotype NIBSC quality assurance panel, 3 were concordant with the expected results, 1 was discordant and 2 could not be amplified by PCR, hence no genotype was determined. This could be due to low viral load.
The study published by Rolfe, Wreghitt et al. 13 assessed both real-time PCR and the NS5B sequencing. Real-time PCR method is capable of detecting mixed genotypes, but the genotype call is less reliable. In contrast, the sequencing PCR gives definitive genotypes but one at a time, this explains why we missed some genotypes on samples with mixed genotypes as noticed from the QCMD external reference HCV panel. Since the real-time PCR genotyping required further improvements, we did not have another method to compare with the sequencing method.
In this project, we attempted to optimize the onestep real-time PCR for HCV genotyping for comparison with the NS5b HCV PCR. The HCV 5-UTR region is not reliable to discriminate subtypes as it is based on single variations as compared to HCV NS5b gene region which provides better subtype discrimination since it is based on more variability than single variation. 13 One-step real-time PCR is better because it is simple to interpret and less time consuming. 14 This was the reason why more effort was put in trying to develop the one-step real-time PCR for HCV genotyping in this project, but could not be successfully developed for comparison with the NS5B sequencing. Few more modifications on the assay were required. Realtime PCR is increasingly becoming an HCV genotyping method in diagnostic laboratories. 15 
CONCLUSION
In Conclusion, the study managed to demonstrate that the PCR amplification of HCV NS5B region could assist in detecting HCV genotypes despite its inability to discriminate mixed genotypes. Such mixed genotypes could easily be detected by RealTime PCR, hence the need to develop the One-Step Real-Time PCR. On the other hand, the sequencing method used in this study has an inherent limitation of giving definitive genotypes one at a time.
